Colitis and Crohn’s Disease Research and CBD (Cannabidiol)
CBD and Your Genes
Can Cannbidiol (or CBD) Support Your DNA? A wealth of previously unknown health benefits show that the phytocannabinoid known as cannabidiol (CBD) holds massive potential as therapeutically useful for treating a variety of ailments. To date, CBD has been found to possess anti-seizure, antioxidant, neuroprotective, anti-inflammatory, analgesic, anti-tumor, anti-psychotic, and anti-anxiety properties. As research into this powerful drug continues, studies... ContinueHealing Without The High: The Shift Towards CBD-Rich Strains
Up until very recently, the cannabis world was all about THC. For years, the quality of cannabis for many recreational and medical users was solely dependent on the THC content of that particular strain. As you probably know, the widely shared belief was that higher concentrations equated to better quality and higher potency. In other words, the more THC, the... Continue
Colitis and Crohn’s Disease Research Continued
- CBD in inflammatory bowel diseases: a brief overview
- Cannabis finds its way into treatment of Crohn’s disease
- CBD reduces intestinal inflammation through the control of neuroimmune axis
- Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
- The effects of Delta-tetrahydrocannabinol and CBD alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
- Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice
- Cannabinoids and the gut: New developments and emerging concepts
- Endocannabinoids and the gastrointestinal tract
- Cannabinoids and gastrointestinal motility: Animal and human studies
- Hergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis
